U.S. Markets closed

Turning Point Therapeutics Inc (TPTX) President & CEO Athena Countouriotis Bought $216,000 ...

- By insider

President & CEO of Turning Point Therapeutics Inc (TPTX) Athena Countouriotis bought 12,000 shares of TPTX on 04/22/2019 at an average price of $18 a share. The total cost of this purchase was $216,000.

Turning Point Therapeutics Inc has a market cap of $837.430 million; its shares were traded at around $28.24 .


CEO Recent Trades:

  • President & CEO Athena Countouriotis bought 12,000 shares of TPTX stock on 04/22/2019 at the average price of $18. The price of the stock has increased by 56.89% since.

Directors and Officers Recent Trades:

  • VP of Finance and Admin. Brian Lee Baker bought 2,800 shares of TPTX stock on 04/22/2019 at the average price of $18. The price of the stock has increased by 56.89% since.
  • Director Advisors Llc Orbimed bought 360,000 shares of TPTX stock on 04/22/2019 at the average price of $18. The price of the stock has increased by 56.89% since.
  • Director Hongbo Lu bought 60,000 shares of TPTX stock on 04/22/2019 at the average price of $18. The price of the stock has increased by 56.89% since.
  • Director Carl L Gordon bought 360,000 shares of TPTX stock on 04/22/2019 at the average price of $18. The price of the stock has increased by 56.89% since.
  • Director Simeon George bought 325,000 shares of TPTX stock on 04/22/2019 at the average price of $18. The price of the stock has increased by 56.89% since.

For the complete insider trading history of TPTX, click here

.This article first appeared on GuruFocus.